Table 1 Baseline clinical and demographic characteristics in the overall study population
Characteristic | Total (n = 84) | Naïve (n = 29) | Nonnaïve (n = 55) | Pa |
|---|---|---|---|---|
Age, years | ||||
Mean (SD) | 71.1 (9.2) | 73.6 (9.1) | 69.7 (9.1) | 0.0465 |
95% CI | 69.1 to 73.1 | 70.3 to 77.2 | 69.7 to 76.4 | |
HbA1c, (%) | ||||
Mean (SD) | 7.6 (0.9) | 7.4 (0.9) | 7.6 (1.0) | 0.2575 |
95% CI | 7.4 to 7.8 | 7.1 to 7.8 | 7.4 to 7.9 | |
Sex, n (%) | ||||
Man | 58 (69.0) | 16 (55.2) | 42 (76.4) | 0.0471b |
Woman | 26 (31.0) | 13 (44.8) | 13 (23.6) | |
Eye, n (%) | ||||
Right | 45 (53.6) | 17 (58.6) | 28 (50.9) | 0.5030b |
Left | 39 (46.4) | 12 (41.4) | 27 (49.1) | |
Type of DME, n (%) | ||||
DRT | 20 (23.8) | 6 (21.4) | 14 (25.5) | |
CME | 41 (48.8) | 12 (42.9) | 28 (50.9) | 0.5089b |
SRD | 23 (27.4) | 10 (35.7) | 13 (23.6) | |
Visual Acuity* | ||||
Mean (SD) | 60.8 (14.6) | 58.8 (16.4) | 61.8 (13.6) | 0.4513 |
95% CI | 57.6 to 63.9 | 52.6 to 65.0 | 58.2 to 65.5 | |
CMT, μm | ||||
Mean (SD) | 448.1 (110.7) | 466.2 (189.7) | 448.1 (110.7) | 0.7348 |
95% CI | 418.2 to 478.0 | 394.0 to 538.3 | 418.2 to 478.3 | |
Number of anti-VEGF injections | ||||
Mean (SD) | N.A. | N.A. | 7.0 (3.9) | N.A. |
95% CI | 5.9 to 8.0 | |||